CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE Share Price

Certificat

DE000KH21DF8

Market Closed - Deutsche Boerse AG 10:57:11 31/05/2024 pm IST
39.84 EUR +0.03% Intraday chart for CAPPED BONUS-ZERTIFIKAT - FRESENIUS MEDICAL CARE
Current month+1.53%
1 month+1.53%
Date Price Change
31/24/31 39.84 +0.03%
30/24/30 39.83 +0.03%
29/24/29 39.82 -.--%
28/24/28 39.82 +0.03%
27/24/27 39.81 +0.08%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 10:57 pm IST

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Citi Citi
WKN KH21DF
ISINDE000KH21DF8
Date issued 30/01/2023
Strike 40
Maturity 20/06/2024 (19 Days)
Parity 1 : 1
Emission price 31.6
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 39.86
Lowest since issue 31.53

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
39.18 EUR
Average target price
39.92 EUR
Spread / Average Target
+1.89%
Consensus